February 16, 2026

Medpace Holdings, Inc. (MEDP) Stock Analysis: Exploring a 14.59% Upside Potential

Medpace Holdings, Inc. (NASDAQ: MEDP) has captured the attention of investors with its impressive growth metrics and a potential upside of 14.59%, making it a compelling..

Corcept Therapeutics (CORT) Stock Analysis: Unlocking a Potential 110% Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT) is a compelling entity within the biotechnology sector, engaging in the development of therapies for severe endocrinologic, oncologic, metabolic, and neurologic..

Merit Medical Systems (MMSI): Investor Outlook Reveals 27.69% Potential Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading player in the medical instruments and supplies industry, offers investors an intriguing proposition with a significant potential upside..

Centene Corporation (CNC) Stock Report: Navigating Healthcare with a 23.10% Revenue Growth Boost

Centene Corporation (CNC), a formidable player in the healthcare sector, particularly within the healthcare plans industry, has been capturing investor attention with its robust revenue growth..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 53% Potential Upside

Investors in the healthcare sector should pay close attention to iRhythm Holdings, Inc. (NASDAQ: IRTC), a company at the forefront of digital healthcare innovation. With a..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 31.92% Upside with Strong Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, continues to capture investor interest with a compelling potential upside of 31.92%. Headquartered in..

CVS Health Corporation (CVS) Stock Rating Update: 20.85% Potential Upside Beckons Investors

CVS Health Corporation (NYSE: CVS) presents a compelling case for investors seeking a balanced opportunity in the healthcare sector. With a market capitalization of $99.84 billion,..

Elevance Health, Inc. (ELV) Stock Analysis: Evaluating a Healthcare Giant’s 11.84% Potential Upside

Elevance Health, Inc. (NYSE: ELV), once known as Anthem, Inc., stands as a behemoth in the healthcare industry with a market capitalization of $76.54 billion. The..

Telix Pharmaceuticals (TLX) Stock Analysis: Exploring a Promising 235% Upside Potential

In the dynamic world of biotechnology, Telix Pharmaceuticals Limited (ASX: TLX) stands out as a compelling investment opportunity. With a remarkable potential upside of 235%, this..

Tempus AI, Inc. (TEM) Stock Analysis: Unveiling a 69.23% Potential Upside in Healthcare Innovation

Tempus AI, Inc. (NASDAQ: TEM) is rapidly emerging as a compelling player in the healthcare technology sector, specifically within the health information services industry. With a..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Deep Dive into Its 26.62% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) is capturing investor attention with its innovative approach to treating RAS-addicted cancers and its enticing potential upside of 26.62%. As a..

Option Care Health, Inc. (OPCH) Stock Analysis: A 12.42% Upside Potential Awaits Investors

Option Care Health, Inc. (NASDAQ: OPCH) has positioned itself as a key player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in..

Guardant Health, Inc. (GH) Stock Analysis: Riding the 19.45% Potential Upside in Precision Oncology

Guardant Health, Inc. (GH) is making waves in the healthcare sector with its innovative approach to diagnostics and research. As a leader in precision oncology, the..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring the 75% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is capturing investor attention with its robust growth trajectory and substantial upside potential. With..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Impressive Revenue Growth and 30.63% Potential Upside for Investors

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is carving a niche in the biotechnology sector with a focus on developing therapeutics for genetic diseases and cancers. Based in..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 44% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is catching the attention of investors with an enticing potential upside of 44.41%. As a prominent player in the biotechnology industry,..

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: Exploring a Potential 18.89% Upside in CNS Innovations

Axsome Therapeutics, Inc. (NASDAQ: AXSM) has become a prominent player in the biotechnology sector, focusing on novel therapies for central nervous system (CNS) disorders. With a..

ADMA Biologics Inc (ADMA) Stock Analysis: Unlocking a 59.52% Upside in the Biotech Arena

ADMA Biologics Inc (NASDAQ: ADMA) stands as a compelling opportunity in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $3.84 billion,..

AstraZeneca PLC (AZN) Stock Analysis: Navigating a -24.17% Potential Downside Amid Strong Revenue Growth

AstraZeneca PLC (NASDAQ: AZN), a stalwart in the healthcare sector, has captured the attention of investors worldwide. With a market capitalization of $318.66 billion, this UK-based..

Nuvalent, Inc. (NUVL) Stock Analysis: A 41.49% Potential Upside in the Biotechnology Sector

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to treating cancer. With a market capitalization..

Search

Funds

February 16, 2026

Search

Funds

February 16, 2026

FTSE 100

Funds